Vertex Pharmaceuticals traded at $445.87 this Monday May 20th, increasing $0.46 or 0.10 percent since the previous trading session. Looking back, over the last four weeks, Vertex Pharmaceuticals gained 11.63 percent. Over the last 12 months, its price rose by 31.15 percent. Looking ahead, we forecast Vertex Pharmaceuticals to be priced at 433.25 by the end of this quarter and at 420.76 in one year, according to Trading Economics global macro models projections and analysts expectations.